BOLT BIOTHERAPEUTICS INC shareholders Q3 2023

BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 36 filers reported holding BOLT BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

BOLT BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Hawkeye Capital Management, LLC 415,039$431,6411.06%
Nan Fung Group Holdings Ltd 1,166,952$1,213,6300.98%
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$1,967,1260.78%
TANG CAPITAL MANAGEMENT LLC 3,557,040$3,699,3220.52%
Vivo Capital, LLC 3,871,291$4,026,1430.44%
Samsara BioCapital, LLC 1,049,153$1,091,1190.33%
Acuitas Investments, LLC 460,379$478,7940.28%
Newtyn Management, LLC 1,020,000$1,060,8000.26%
Sofinnova Investments, Inc. 2,754,437$2,864,6140.18%
Privium Fund Management (UK) Ltd 116,516$121,1770.10%
Board of Trustees of The Leland Stanford Junior University 757,097$787,3810.06%
Orbimed Advisors 1,541,000$1,602,6400.03%
Marquette Asset Management, LLC 97,835$101,7490.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 111,200$115,6480.00%
ADAGE CAPITAL PARTNERS GP, L.L.C. 500,000$520,0000.00%
Renaissance Technologies 314,189$3270.00%
Citadel Advisors 2,853,634$2,967,7800.00%
WELLS FARGO & COMPANY/MN 197$2050.00%
NORTHERN TRUST CORP 31,182$32,4290.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
External links

This page lists BOLT BIOTHERAPEUTICS INC's shareholders in Q3 2023. To view BOLT BIOTHERAPEUTICS INC's shareholder history, click here.